Danone has acquired The Akkermansia Company to enhance its presence in the gut health sector with innovative probiotic products.
Overview of The Akkermansia Company (TAC)
VIVES Partners announced the acquisition of The Akkermansia Company (TAC) by Danone, a move that underscores Danone's commitment to expanding into the gut health market. Founded in 2016, TAC specializes in biotics and is renowned for its innovative product, Akkermansia muciniphila MucT®, a probiotic strain pivotal for maintaining gut health. This bacterium is naturally occurring in the intestine and serves as a protector of the gut barrier, aiding in inflammation reduction and managing metabolic syndromes such as obesity, diabetes, and cardiovascular diseases.
TAC was established by Professor Willem M. de Vos from Wageningen University and Professor Patrice D. Cani from UCLouvain, who have been instrumental in identifying and researching Akkermansia, a strain recognized globally for its health benefits. The acquisition by Danone is a significant milestone, providing the company with a unique asset to promote Akkermansia on a broader scale.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Belgium
The biotic sector is gaining increasing recognition, particularly in Belgium, where a strong focus on health and wellness has accelerated market growth. Consumers are moving towards preventive health measur
Similar Deals
Danone
invested in
The Akkermansia Company (TAC)
in 2025
in a Buyout deal